Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy

The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody and neutralization titers are reduced in a subset of thoracic radiotherapy patients, possibly due to immunosuppressive condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowes, Cynthia L., Naranbhai, Vivek, St. Denis, Kerri J., Lam, Evan C., Bertaux, Brittany, Keane, Florence K., Khandekar, Melin J., Balazs, Alejandro B., Iafrate, John A., Gainor, Justin F., Willers, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613981/
https://www.ncbi.nlm.nih.gov/pubmed/34838892
http://dx.doi.org/10.1016/j.radonc.2021.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613981/
https://www.ncbi.nlm.nih.gov/pubmed/34838892
http://dx.doi.org/10.1016/j.radonc.2021.11.012

Ejemplares similares